Alessandra Lauria

Alessandra Lauria

Auto-generated profile, based on publicly available information

Alessandra Lauria

UOC Neuroriabilitazione ad Alta Intensità, Fondazione Policlinico Universitario A. Gemelli IRCCS

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2022 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
MNMatteo Nardini
Matteo Nardini
GCGabriele Ciasca
Gabriele Ciasca
ALAlessandra Lauria
Alessandra Lauria
CRCristina Rossi
Cristina Rossi
FGFlavio Di Giacinto
Flavio Di Giacinto
Marco De SpiritoMarco De Spirito
Marco De Spirito
Red blood cells (RBCs) are characterized by a remarkable elasticity, which allows them to undergo very large deformation when passing through small vessels and capillaries. This extreme deformability is altered in various clinical conditions, suggesting that the analysis of red blood cell (RBC) mechanics has potential applications in the search for non-invasive and cost-effective blood biomarkers. Here, we provide a comparative study of the mechanical response of RBCs in patients with Alzheimer’s disease (AD) and healthy subjects. For this purpose, RBC viscoelastic response was investigated using atomic force microscopy (AFM) in the force spectroscopy mode. Two types of analyses were performed: (i) a conventional analysis of AFM force–distance (FD) curves, which allowed us to retrieve the apparent Young’s modulus, E; and (ii) a more in-depth analysis of time-dependent relaxation curves in the framework of the standard linear solid (SLS) model, which allowed us to estimate cell viscosity and elasticity, independently. Our data demonstrate that, while conventional analysis of AFM FD curves fails in distinguishing the two groups, the mechanical parameters obtained with the SLS model show a very good classification ability. The diagnostic performance of mechanical parameters was assessed using receiving operator characteristic (ROC) curves, showing very large areas under the curves (AUC) for selected biomarkers (AUC > 0.9). Taken all together, the data presented here demonstrate that RBC mechanics are significantly altered in AD, also highlighting the key role played by viscous forces. These RBC abnormalities in AD, which include both a modified elasticity and viscosity, could be considered a potential source of plasmatic biomarkers in the field of liquid biopsy to be used in combination with more established indicators of the pathology.

7 March 2008 in Dementia and Geriatric Cognitive Disorders
Verified
Journal Article
Closed access
PDF file
CGClaudia Giannattasio
Claudia Giannattasio
APAnna Poleggi
Anna Poleggi
MPMaria Puopolo
Maria Puopolo
MPMaurizio Pocchiari
Maurizio Pocchiari
PAPiero Antuono
Piero Antuono
CMCarlo Masullo
Carlo Masullo
We assessed the role of the APOE genotype and prion protein polymorphism at codon 129 in predicting the clinical duration of 92 neuropathologically confirmed sporadic Alzheimer’s disease patients. Analyses of survival showed that the absence of the APOE Ε4 allele in heterozygous codon 129 PRNP carriers is a negative predictor of survival. When this subgroup of patients was stratified by sex, the effect of APOE was observed in women, but not in men.

22 July 2025 in Journal of the American Nutrition Association
Verified
Journal Article
Closed access
Silvia GiovanniniSilvia Giovannini
Silvia Giovannini
ALAlessandra Lauria
Alessandra Lauria
AMAnna Maria Malizia
Anna Maria Malizia
ELElisabetta Lama
Elisabetta Lama
NMNadia Morciano
Nadia Morciano
LCLetizia Castelli
Letizia Castelli
Frailty, falls, and disability are related to aging, which involves a decline in biological function. Proper nutrition can reduce frailty. When consumed in significant quantities, phytochemical compounds carry out a variety of biological tasks. Altermor®, a nutritional supplement containing hesperidin, diosmin and proanthocyanidins, optimizes blood microcirculation. The purpose of the study is to evaluate improvements in cognitive function, balance, fatigue, and some aspects of quality of life by introducing supplementation with Altemor® in the elderly. This is a randomized, crossover-controlled pilot study. Thirty-six elderly patients were randomized into three groups: G-ALT12, G-ALT21, and G-CON. G-ALT12 patients took 1 stick/day of Altemor® for 8 wk, did 4 wk of wash-out, and then took 2 sticks/day of Altemor® for another 8 wk; G-Alt21 patients took 2 sticks/day of Altemor® for 8 wk, did 4 wk of wash-out, and then took 1 stick/day of Altemor® for another 8 wk. G-CON patients took any supplements beyond their daily routine. All patients were assessed at baseline, after 8 wk, after 12 wk, and after 20 wk for cognitive and motor performance, mood, fatigue, and quality of life. After 1 week and 13 wk, patients were evaluated for attention only. Both experimental groups showed statistically significant differences from the control group in cognitive function, particularly attention, and fall risk. No domains showed statistically significant differences between the two experimental groups. No significant differences were found in any domain when comparing the two experimental doses (1 stick/day vs. 2 sticks/day). In the older adults, dietary supplementation with hesperidin, diosmin and proanthocyanidins showed a positive effect on improving cognitive functions (attention, learning, memory) as well as significantly reducing the risk of falling. In the future, the use of Altermor® should be studied in moderate cognitive impairment and other cognitive disorders. Trial registration. NCT06352099.